Literature DB >> 29160301

New insights into the pharmacogenomics of antidepressant response from the GENDEP and STAR*D studies: rare variant analysis and high-density imputation.

C Fabbri1,2, K E Tansey3, R H Perlis4, J Hauser5, N Henigsberg6, W Maier7, O Mors8, A Placentino9, M Rietschel10, D Souery11, G Breen2, C Curtis2, L Sang-Hyuk2, S Newhouse2, H Patel2, M Guipponi12, N Perroud13, G Bondolfi13, M O'Donovan14, G Lewis15, J M Biernacka16,17, R M Weinshilboum18, A Farmer2, K J Aitchison19, I Craig2, P McGuffin2, R Uher20, C M Lewis2.   

Abstract

Genome-wide association studies have generally failed to identify polymorphisms associated with antidepressant response. Possible reasons include limited coverage of genetic variants that this study tried to address by exome genotyping and dense imputation. A meta-analysis of Genome-Based Therapeutic Drugs for Depression (GENDEP) and Sequenced Treatment Alternatives to Relieve Depression (STAR*D) studies was performed at the single-nucleotide polymorphism (SNP), gene and pathway levels. Coverage of genetic variants was increased compared with previous studies by adding exome genotypes to previously available genome-wide data and using the Haplotype Reference Consortium panel for imputation. Standard quality control was applied. Phenotypes were symptom improvement and remission after 12 weeks of antidepressant treatment. Significant findings were investigated in NEWMEDS consortium samples and Pharmacogenomic Research Network Antidepressant Medication Pharmacogenomic Study (PGRN-AMPS) for replication. A total of 7062 950 SNPs were analyzed in GENDEP (n=738) and STAR*D (n=1409). rs116692768 (P=1.80e-08, ITGA9 (integrin α9)) and rs76191705 (P=2.59e-08, NRXN3 (neurexin 3)) were significantly associated with symptom improvement during citalopram/escitalopram treatment. At the gene level, no consistent effect was found. At the pathway level, the Gene Ontology (GO) terms GO: 0005694 (chromosome) and GO: 0044427 (chromosomal part) were associated with improvement (corrected P=0.007 and 0.045, respectively). The association between rs116692768 and symptom improvement was replicated in PGRN-AMPS (P=0.047), whereas rs76191705 was not. The two SNPs did not replicate in NEWMEDS. ITGA9 codes for a membrane receptor for neurotrophins and NRXN3 is a transmembrane neuronal adhesion receptor involved in synaptic differentiation. Despite their meaningful biological rationale for being involved in antidepressant effect, replication was partial. Further studies may help in clarifying their role.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 29160301     DOI: 10.1038/tpj.2017.44

Source DB:  PubMed          Journal:  Pharmacogenomics J        ISSN: 1470-269X            Impact factor:   3.550


  78 in total

1.  Convergence of linkage, association and GWAS findings for a candidate region for bipolar disorder and schizophrenia on chromosome 4p.

Authors:  A Christoforou; K A McGhee; S W Morris; P A Thomson; S Anderson; A McLean; H S Torrance; S Le Hellard; B S Pickard; D StClair; W J Muir; D H Blackwood; D J Porteous; K L Evans
Journal:  Mol Psychiatry       Date:  2010-03-30       Impact factor: 15.992

2.  Principal components analysis corrects for stratification in genome-wide association studies.

Authors:  Alkes L Price; Nick J Patterson; Robert M Plenge; Michael E Weinblatt; Nancy A Shadick; David Reich
Journal:  Nat Genet       Date:  2006-07-23       Impact factor: 38.330

3.  Development of a rating scale for primary depressive illness.

Authors:  M Hamilton
Journal:  Br J Soc Clin Psychol       Date:  1967-12

4.  Data quality control in genetic case-control association studies.

Authors:  Carl A Anderson; Fredrik H Pettersson; Geraldine M Clarke; Lon R Cardon; Andrew P Morris; Krina T Zondervan
Journal:  Nat Protoc       Date:  2010-08-26       Impact factor: 13.491

Review 5.  Antidepressant drug effects and depression severity: a patient-level meta-analysis.

Authors:  Jay C Fournier; Robert J DeRubeis; Steven D Hollon; Sona Dimidjian; Jay D Amsterdam; Richard C Shelton; Jan Fawcett
Journal:  JAMA       Date:  2010-01-06       Impact factor: 56.272

6.  Long-term suicide risk of depression in the Lundby cohort 1947-1997--severity and gender.

Authors:  L Brådvik; C Mattisson; M Bogren; P Nettelbladt
Journal:  Acta Psychiatr Scand       Date:  2008-01-10       Impact factor: 6.392

7.  Population structure and eigenanalysis.

Authors:  Nick Patterson; Alkes L Price; David Reich
Journal:  PLoS Genet       Date:  2006-12       Impact factor: 5.917

8.  Homozygous loss-of-function variants in European cosmopolitan and isolate populations.

Authors:  Vera B Kaiser; Victoria Svinti; James G Prendergast; You-Ying Chau; Archie Campbell; Inga Patarcic; Inês Barroso; Peter K Joshi; Nicholas D Hastie; Ana Miljkovic; Martin S Taylor; Stefan Enroth; Yasin Memari; Anja Kolb-Kokocinski; Alan F Wright; Ulf Gyllensten; Richard Durbin; Igor Rudan; Harry Campbell; Ozren Polašek; Åsa Johansson; Sascha Sauer; David J Porteous; Ross M Fraser; Camilla Drake; Veronique Vitart; Caroline Hayward; Colin A Semple; James F Wilson
Journal:  Hum Mol Genet       Date:  2015-07-14       Impact factor: 6.150

9.  A reference panel of 64,976 haplotypes for genotype imputation.

Authors:  Shane McCarthy; Sayantan Das; Warren Kretzschmar; Olivier Delaneau; Andrew R Wood; Alexander Teumer; Hyun Min Kang; Christian Fuchsberger; Petr Danecek; Kevin Sharp; Yang Luo; Carlo Sidore; Alan Kwong; Nicholas Timpson; Seppo Koskinen; Scott Vrieze; Laura J Scott; He Zhang; Anubha Mahajan; Jan Veldink; Ulrike Peters; Carlos Pato; Cornelia M van Duijn; Christopher E Gillies; Ilaria Gandin; Massimo Mezzavilla; Arthur Gilly; Massimiliano Cocca; Michela Traglia; Andrea Angius; Jeffrey C Barrett; Dorrett Boomsma; Kari Branham; Gerome Breen; Chad M Brummett; Fabio Busonero; Harry Campbell; Andrew Chan; Sai Chen; Emily Chew; Francis S Collins; Laura J Corbin; George Davey Smith; George Dedoussis; Marcus Dorr; Aliki-Eleni Farmaki; Luigi Ferrucci; Lukas Forer; Ross M Fraser; Stacey Gabriel; Shawn Levy; Leif Groop; Tabitha Harrison; Andrew Hattersley; Oddgeir L Holmen; Kristian Hveem; Matthias Kretzler; James C Lee; Matt McGue; Thomas Meitinger; David Melzer; Josine L Min; Karen L Mohlke; John B Vincent; Matthias Nauck; Deborah Nickerson; Aarno Palotie; Michele Pato; Nicola Pirastu; Melvin McInnis; J Brent Richards; Cinzia Sala; Veikko Salomaa; David Schlessinger; Sebastian Schoenherr; P Eline Slagboom; Kerrin Small; Timothy Spector; Dwight Stambolian; Marcus Tuke; Jaakko Tuomilehto; Leonard H Van den Berg; Wouter Van Rheenen; Uwe Volker; Cisca Wijmenga; Daniela Toniolo; Eleftheria Zeggini; Paolo Gasparini; Matthew G Sampson; James F Wilson; Timothy Frayling; Paul I W de Bakker; Morris A Swertz; Steven McCarroll; Charles Kooperberg; Annelot Dekker; David Altshuler; Cristen Willer; William Iacono; Samuli Ripatti; Nicole Soranzo; Klaudia Walter; Anand Swaroop; Francesco Cucca; Carl A Anderson; Richard M Myers; Michael Boehnke; Mark I McCarthy; Richard Durbin
Journal:  Nat Genet       Date:  2016-08-22       Impact factor: 38.330

10.  Genetic predictors of response to serotonergic and noradrenergic antidepressants in major depressive disorder: a genome-wide analysis of individual-level data and a meta-analysis.

Authors:  Katherine E Tansey; Michel Guipponi; Nader Perroud; Guido Bondolfi; Enrico Domenici; David Evans; Stephanie K Hall; Joanna Hauser; Neven Henigsberg; Xiaolan Hu; Borut Jerman; Wolfgang Maier; Ole Mors; Michael O'Donovan; Tim J Peters; Anna Placentino; Marcella Rietschel; Daniel Souery; Katherine J Aitchison; Ian Craig; Anne Farmer; Jens R Wendland; Alain Malafosse; Peter Holmans; Glyn Lewis; Cathryn M Lewis; Tine Bryan Stensbøl; Shitij Kapur; Peter McGuffin; Rudolf Uher
Journal:  PLoS Med       Date:  2012-10-16       Impact factor: 11.069

View more
  12 in total

1.  Identifying the Common Genetic Basis of Antidepressant Response.

Authors:  Oliver Pain; Karen Hodgson; Vassily Trubetskoy; Stephan Ripke; Victoria S Marshe; Mark J Adams; Enda M Byrne; Adrian I Campos; Tania Carrillo-Roa; Annamaria Cattaneo; Thomas D Als; Daniel Souery; Mojca Z Dernovsek; Chiara Fabbri; Caroline Hayward; Neven Henigsberg; Joanna Hauser; James L Kennedy; Eric J Lenze; Glyn Lewis; Daniel J Müller; Nicholas G Martin; Benoit H Mulsant; Ole Mors; Nader Perroud; David J Porteous; Miguel E Rentería; Charles F Reynolds; Marcella Rietschel; Rudolf Uher; Eleanor M Wigmore; Wolfgang Maier; Naomi R Wray; Katherine J Aitchison; Volker Arolt; Bernhard T Baune; Joanna M Biernacka; Guido Bondolfi; Katharina Domschke; Masaki Kato; Qingqin S Li; Yu-Li Liu; Alessandro Serretti; Shih-Jen Tsai; Gustavo Turecki; Richard Weinshilboum; Andrew M McIntosh; Cathryn M Lewis
Journal:  Biol Psychiatry Glob Open Sci       Date:  2022-04

2.  5-HTTLPR and MTHFR 677C>T polymorphisms and response to yoga-based lifestyle intervention in major depressive disorder: A randomized active-controlled trial.

Authors:  Madhuri R Tolahunase; Rajesh Sagar; Rima Dada
Journal:  Indian J Psychiatry       Date:  2018 Oct-Dec       Impact factor: 1.759

3.  Genome-wide association study of seasonal affective disorder.

Authors:  Kwo Wei David Ho; Shizhong Han; Jakob V Nielsen; Dubravka Jancic; Benjamin Hing; Jess Fiedorowicz; Myrna M Weissman; Douglas F Levinson; James B Potash
Journal:  Transl Psychiatry       Date:  2018-09-14       Impact factor: 6.222

4.  Combination of Genome-Wide Polymorphisms and Copy Number Variations of Pharmacogenes in Koreans.

Authors:  Nayoung Han; Jung Mi Oh; In-Wha Kim
Journal:  J Pers Med       Date:  2021-01-07

5.  ERICH3: vesicular association and antidepressant treatment response.

Authors:  Duan Liu; Yongxian Zhuang; Lingxin Zhang; Huanyao Gao; Drew Neavin; Tania Carrillo-Roa; Yani Wang; Jia Yu; Sisi Qin; Daniel C Kim; Erica Liu; Thanh Thanh Le Nguyen; Joanna M Biernacka; Rima Kaddurah-Daouk; Boadie W Dunlop; W Edward Craighead; Helen S Mayberg; Elisabeth B Binder; Mark A Frye; Liewei Wang; Richard M Weinshilboum
Journal:  Mol Psychiatry       Date:  2020-11-23       Impact factor: 13.437

6.  Optimizing prediction of response to antidepressant medications using machine learning and integrated genetic, clinical, and demographic data.

Authors:  Dekel Taliaz; Amit Spinrad; Ran Barzilay; Zohar Barnett-Itzhaki; Dana Averbuch; Omri Teltsh; Roy Schurr; Sne Darki-Morag; Bernard Lerer
Journal:  Transl Psychiatry       Date:  2021-07-08       Impact factor: 6.222

7.  Genes associated with anhedonia: a new analysis in a large clinical trial (GENDEP).

Authors:  Hongyan Ren; Chiara Fabbri; Rudolf Uher; Marcella Rietschel; Ole Mors; Neven Henigsberg; Joanna Hauser; Astrid Zobel; Wolfgang Maier; Mojca Z Dernovsek; Daniel Souery; Annamaria Cattaneo; Gerome Breen; Ian W Craig; Anne E Farmer; Peter McGuffin; Cathryn M Lewis; Katherine J Aitchison
Journal:  Transl Psychiatry       Date:  2018-08-13       Impact factor: 6.222

8.  A polygenic predictor of treatment-resistant depression using whole exome sequencing and genome-wide genotyping.

Authors:  Chiara Fabbri; Siegfried Kasper; Alexander Kautzky; Joseph Zohar; Daniel Souery; Stuart Montgomery; Diego Albani; Gianluigi Forloni; Panagiotis Ferentinos; Dan Rujescu; Julien Mendlewicz; Rudolf Uher; Cathryn M Lewis; Alessandro Serretti
Journal:  Transl Psychiatry       Date:  2020-02-03       Impact factor: 6.222

9.  Targeted exome sequencing identifies five novel loci at genome-wide significance for modulating antidepressant response in patients with major depressive disorder.

Authors:  Zhi Xu; Chunming Xie; Lu Xia; Yonggui Yuan; Hong Zhu; Xiaofa Huang; Caihua Li; Yu Tao; Xiaoxiao Qu; Fengyu Zhang; Zhijun Zhang
Journal:  Transl Psychiatry       Date:  2020-01-23       Impact factor: 6.222

10.  Genome-wide association studies of antidepressant class response and treatment-resistant depression.

Authors:  Qingqin S Li; Chao Tian; David Hinds
Journal:  Transl Psychiatry       Date:  2020-10-26       Impact factor: 6.222

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.